DAPK1 has also been associated with resistance to imatinib in chronic myeloid leukemia (Guru et al., 2022), autophagia (Singh et al., 2016), alterations in the p53 signaling pathway in chronic lymphocytic leukemia (Wang et al., 2014) and methylated in myelodysplastic syndrome (Greco et al., 2010). The gene discussed is DAPK1; the disease is myelodysplastic syndrome.